Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenqiang Yan

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Research (Washington, D.C.)|December 24, 2024
Vascular Smooth Muscle Cells Transdifferentiate into Chondrocyte-Like Cells and Facilitate Meniscal Fibrocartilage RegenerationWenqiang Yan, Jin Cheng, Haoda Wu, et al.
Journal of Orthopaedic Translation|March 1, 2022
Intraarticular injection of SHP2 inhibitor SHP099 promotes the repair of rabbit full-thickness cartilage defectZiying Sun, Xingquan Xu, Zhongyang Lv, et al.
Annals of Hematology|December 4, 2023
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM)Lihui Shi, Wenqiang Yan, Jingyu Xu, et al.
Nature Communications|November 22, 2022
Cholesterol-induced LRP3 downregulation promotes cartilage degeneration in osteoarthritis by targeting Syndecan-4Chenxi Cao, Yuanyuan Shi, Xin Zhang, et al.
Annals of Hematology|September 24, 2023
Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature reviewWenqiang Yan, Rui Lv, Jingyu Xu, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 29, 2025
The Monoclonal Gammopathy of Undetermined Significance-Like (MGUS-like) Classifier Stratifies Prognosis in Multiple Myeloma: Results from Real-World Data in Chinese PopulationWenqiang Yan, Jieqiong Zhou, Yuntong Liu, et al.
Haematologica|August 3, 2023
Minor clone of del(17p) provides a reservoir for relapse in multiple myelomaJian Cui, Rui Lv, Tengteng Yu, et al.
Cancer Research Communications|September 8, 2023
Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction TreatmentJiahui Liu, Wenqiang Yan, Huishou Fan, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Longitudinal genetically detectable minimal residual disease by fluorescence <i>in situ</i> hybridization confers a poor prognosis in myelomaJian Cui, Tengteng Yu, Rui Lv, et al.
Leukemia|April 12, 2024
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myelomaJian Cui, Yuntong Liu, Rui Lv, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Research (Washington, D.C.)|December 24, 2024
Vascular Smooth Muscle Cells Transdifferentiate into Chondrocyte-Like Cells and Facilitate Meniscal Fibrocartilage RegenerationWenqiang Yan, Jin Cheng, Haoda Wu, et al.
Journal of Orthopaedic Translation|March 1, 2022
Intraarticular injection of SHP2 inhibitor SHP099 promotes the repair of rabbit full-thickness cartilage defectZiying Sun, Xingquan Xu, Zhongyang Lv, et al.
Annals of Hematology|December 4, 2023
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM)Lihui Shi, Wenqiang Yan, Jingyu Xu, et al.
Nature Communications|November 22, 2022
Cholesterol-induced LRP3 downregulation promotes cartilage degeneration in osteoarthritis by targeting Syndecan-4Chenxi Cao, Yuanyuan Shi, Xin Zhang, et al.
Annals of Hematology|September 24, 2023
Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature reviewWenqiang Yan, Rui Lv, Jingyu Xu, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 29, 2025
The Monoclonal Gammopathy of Undetermined Significance-Like (MGUS-like) Classifier Stratifies Prognosis in Multiple Myeloma: Results from Real-World Data in Chinese PopulationWenqiang Yan, Jieqiong Zhou, Yuntong Liu, et al.
Haematologica|August 3, 2023
Minor clone of del(17p) provides a reservoir for relapse in multiple myelomaJian Cui, Rui Lv, Tengteng Yu, et al.
Cancer Research Communications|September 8, 2023
Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction TreatmentJiahui Liu, Wenqiang Yan, Huishou Fan, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Longitudinal genetically detectable minimal residual disease by fluorescence <i>in situ</i> hybridization confers a poor prognosis in myelomaJian Cui, Tengteng Yu, Rui Lv, et al.
Leukemia|April 12, 2024
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myelomaJian Cui, Yuntong Liu, Rui Lv, et al.
Pageof 12